Greenwich LifeSciences Statistics Share Statistics Greenwich LifeSciences has 13.63M
shares outstanding. The number of shares has increased by 3.69%
in one year.
Shares Outstanding 13.63M Shares Change (YoY) 3.69% Shares Change (QoQ) 1.96% Owned by Institutions (%) 9.03% Shares Floating 6.37M Failed to Deliver (FTD) Shares 9,448 FTD / Avg. Volume 13.54%
Short Selling Information The latest short interest is 1.23M, so 9.23% of the outstanding
shares have been sold short.
Short Interest 1.23M Short % of Shares Out 9.23% Short % of Float 19.33% Short Ratio (days to cover) 13.94
Valuation Ratios The PE ratio is -9.26 and the forward
PE ratio is -7.2.
Greenwich LifeSciences's PEG ratio is
-0.12.
PE Ratio -9.26 Forward PE -7.2 PS Ratio 0 Forward PS n/a PB Ratio 57.68 P/FCF Ratio -20.11 PEG Ratio -0.12
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Greenwich LifeSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.62,
with a Debt / Equity ratio of 0.
Current Ratio 2.62 Quick Ratio 2.62 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.95M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -20.6% in the
last 52 weeks. The beta is 3.1, so Greenwich LifeSciences's
price volatility has been higher than the market average.
Beta 3.1 52-Week Price Change -20.6% 50-Day Moving Average 11.41 200-Day Moving Average 11.02 Relative Strength Index (RSI) 48.97 Average Volume (20 Days) 69,761
Income Statement
Revenue n/a Gross Profit -3.61K Operating Income -16.01M Net Income -15.79M EBITDA -15.79M EBIT -15.79M Earnings Per Share (EPS) -1.21
Full Income Statement Balance Sheet The company has 4.09M in cash and 0 in
debt, giving a net cash position of 4.09M.
Cash & Cash Equivalents 4.09M Total Debt n/a Net Cash n/a Retained Earnings -66.15M Total Assets 2.75M Working Capital 1.31M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.27M
and capital expenditures 3, giving a free cash flow of -7.27M.
Operating Cash Flow -7.27M Capital Expenditures 3 Free Cash Flow -7.27M FCF Per Share -0.56
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
